Company:  INSPIREMD, INC. (NSPR)
Form Type:  8-K
Filing Date:  10/25/2013 
CIK:  0001433607 
Address:  321 COLUMBUS AVENUE 
City, State, Zip:  BOSTON, Massachusetts 02116 
Telephone:  (857) 453-6553 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$0.43  
Change: 
-0.009 (-2.16%)  
Trade Time: 
09:44 AM EST  
Market Cap: 
$4.62M
Trade NSPR now with 

© 2016  
Description of Business
We are a medical device company focusing on the development and commercialization of our proprietary MicroNet(TM) stent platform technology for the treatment of complex vascular and coronary disease. A stent is an expandable "scaffold-like" device, usually constructed of a metallic material, that is inserted into an artery to expand the inside passage and improve blood flow. Our MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Our CGuard(TM) carotid embolic prevention system ("CGuard EPS") combines our MicroNet mesh and a self-expandable nitinol stent in a single device for use in carotid artery applications. Our CGuard EPS received CE mark approval in the European Union in March 2013, and we launched its release on a limited basis in October 2014.
Register and access this filing in:     
  FORM 8-K
    SECTION 1 BUSINESS AND OPERATIONS
      Item 1.01. Entry into a Material Definitive Agreement.
    SECTION 2 FINANCIAL INFORMATION
      Item 2.03. Creation of a Direct Financial Obligation or an ...
    SECTION 3 SECURITIES AND TRADING MARKETS
      Item 3.02. Unregistered Sales of Equity Securities.
      Item 3.03. Material Modifications to Rights of Security Holders.
    SECTION 5 CORPORATE GOVERNANCE
      Item 5.03. Amendment to Articles of Incorporation or Bylaws; ...
    SECTION 8 OTHER EVENTS
      Item 8.01 Other Events.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01. Financial Statements and Exhibits.
    SIGNATURE
  EXHIBIT 3.1
    Section 10. Amendment. The Amended and Restated Certificate ...
  EXHIBIT 10.1
  EXHIBIT 10.2
  EXHIBIT 10.3
  EXHIBIT 10.4
  EXHIBIT 10.5
  EXHIBIT 99.1
  EXHIBIT 99.2
  EXHIBIT 99.3